132 related articles for article (PubMed ID: 12650699)
1. Sex steroid hormones act as growth factors.
Migliaccio A; Castoria G; Di Domenico M; de Falco A; Bilancio A; Lombardi M; Bottero D; Varricchio L; Nanayakkara M; Rotondi A; Auricchio F
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):31-5. PubMed ID: 12650699
[TBL] [Abstract][Full Text] [Related]
2. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells.
Castoria G; Migliaccio A; Bilancio A; Di Domenico M; de Falco A; Lombardi M; Fiorentino R; Varricchio L; Barone MV; Auricchio F
EMBO J; 2001 Nov; 20(21):6050-9. PubMed ID: 11689445
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.
Migliaccio A; Piccolo D; Castoria G; Di Domenico M; Bilancio A; Lombardi M; Gong W; Beato M; Auricchio F
EMBO J; 1998 Apr; 17(7):2008-18. PubMed ID: 9524123
[TBL] [Abstract][Full Text] [Related]
4. Rapid signalling pathway activation by androgens in epithelial and stromal cells.
Castoria G; Lombardi M; Barone MV; Bilancio A; Di Domenico M; De Falco A; Varricchio L; Bottero D; Nanayakkara M; Migliaccio A; Auricchio F
Steroids; 2004 Aug; 69(8-9):517-22. PubMed ID: 15288763
[TBL] [Abstract][Full Text] [Related]
5. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
Castoria G; Barone MV; Di Domenico M; Bilancio A; Ametrano D; Migliaccio A; Auricchio F
EMBO J; 1999 May; 18(9):2500-10. PubMed ID: 10228164
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
7. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens.
Silva E; Kabil A; Kortenkamp A
Toxicol Appl Pharmacol; 2010 Jun; 245(2):160-70. PubMed ID: 20206645
[TBL] [Abstract][Full Text] [Related]
9. Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells.
Castoria G; Migliaccio A; Di Domenico M; Lombardi M; de Falco A; Varricchio L; Bilancio A; Barone MV; Auricchio F
Mol Cell Biol; 2004 Sep; 24(17):7643-53. PubMed ID: 15314172
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.
Castoria G; Giovannelli P; Lombardi M; De Rosa C; Giraldi T; de Falco A; Barone MV; Abbondanza C; Migliaccio A; Auricchio F
Oncogene; 2012 Nov; 31(46):4868-77. PubMed ID: 22266855
[TBL] [Abstract][Full Text] [Related]
11. Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity.
Wessler S; Otto C; Wilck N; Stangl V; Fritzemeier KH
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):25-35. PubMed ID: 16203130
[TBL] [Abstract][Full Text] [Related]
12. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors.
Auricchio F; Migliaccio A; Castoria G
Steroids; 2008 Oct; 73(9-10):880-4. PubMed ID: 18342899
[TBL] [Abstract][Full Text] [Related]
13. Src-dependent signalling pathway regulation by sex-steroid hormones: therapeutic implications.
Migliaccio A; Castoria G; Auricchio F
Int J Biochem Cell Biol; 2007; 39(7-8):1343-8. PubMed ID: 17329144
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio A; Di Domenico M; Castoria G; de Falco A; Bontempo P; Nola E; Auricchio F
EMBO J; 1996 Mar; 15(6):1292-300. PubMed ID: 8635462
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.
Taylor CC
Endocrinology; 2000 Apr; 141(4):1545-53. PubMed ID: 10746662
[TBL] [Abstract][Full Text] [Related]
16. Src tyrosine kinase-induced loss of luteinizing hormone responsiveness is via a Ras-dependent, phosphatidylinositol-3-kinase independent pathway.
Taylor CC
Biol Reprod; 2002 Sep; 67(3):789-94. PubMed ID: 12193386
[TBL] [Abstract][Full Text] [Related]
17. Receptor mechanisms mediating non-genomic actions of sex steroids.
Boonyaratanakornkit V; Edwards DP
Semin Reprod Med; 2007 May; 25(3):139-53. PubMed ID: 17447204
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.
Nebigil CG; Launay JM; Hickel P; Tournois C; Maroteaux L
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2591-6. PubMed ID: 10688905
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor alpha tyrosine-phosphorylated peptide.
Varricchio L; Migliaccio A; Castoria G; Yamaguchi H; de Falco A; Di Domenico M; Giovannelli P; Farrar W; Appella E; Auricchio F
Mol Cancer Res; 2007 Nov; 5(11):1213-21. PubMed ID: 18025264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
